ZIOPHARM Oncology Inc (ZIOP):企業財務及び戦略的SWOT分析

◆英語タイトル:ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH24573FSA
◆発行会社(調査会社):GlobalData
◆発行日:2017年1月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:米国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥32,100見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,200見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥96,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ZIOPHARM Oncology Inc (ZIOPHARM), formerly EasyWeb, Inc. is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to deliver safe, effective and scalable cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD). It offers engineering techniques and multi-genic gene programs to develop next-generation patient- and donor-derived adoptive cellular therapies. ZIOPHARM’s pipeline products include Ad-RTS-IL-12 and CAR/Cytokine Products. The company’s technology platforms include RheoSwitch therapeutic system, UltraVector, adoptive cell therapy, ActoBiotics, AttSite Recombinases and Leap among others. Its products and technologies are used in the treatment of hematologic malignancies, solid tumors and graft-versus-host-disease. ZIOPHARM is headquartered in Boston, Massachusetts, the US.

ZIOPHARM Oncology Inc Key Recent Developments

Nov 09, 2016: ZIOPHARM Reports Third Quarter 2016 Financial Results and Provides Update on Recent Activities
Aug 09, 2016: ZIOPHARM Reports Second-Quarter 2016 Financial Results and Provides Update on Recent Activities
Jul 15, 2016: Federman & Sherwood Investigates ZIOPHARM Oncology for Possible Violations of Federal Securities Laws
May 10, 2016: ZIOPHARM Reports First-Quarter 2016 Financial Results and Provides Update on Recent Activities
Feb 24, 2016: ZIOPHARM Reports Fourth-Quarter 2015 Financial Results and Provides Update on Recent Activities

This comprehensive SWOT profile of ZIOPHARM Oncology Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZIOPHARM Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*, _x000D_
_x000D_
- Business description – A detailed description of the company’s operations and business divisions._x000D_
- Corporate strategy – Analyst’s summarization of the company’s business strategy._x000D_
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats._x000D_
- Company history – Progression of key events associated with the company._x000D_
- Major products and services – A list of major products, services and brands of the company._x000D_
- Key competitors – A list of key competitors to the company._x000D_
- Key employees – A list of the key executives of the company._x000D_
- Executive biographies – A brief summary of the executives’ employment history._x000D_
- Key operational heads – A list of personnel heading key departments/functions._x000D_
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company._x000D_
- Key manufacturing facilities – A list of key manufacturing facilities of the company._x000D_
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history._x000D_
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history._x000D_
_x000D_
Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,_x000D_
_x000D_
You get detailed information about the company and its operations to identify potential customers and suppliers._x000D_
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors._x000D_
_x000D_
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company._x000D_
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. _x000D_
_x000D_
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably._x000D_
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted._x000D_
_x000D_
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance._x000D_
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios._x000D_
_x000D_
Gain key insights into the company for academic or business research._x000D_
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents
_x000D_
Section 1 – About the Company _x000D_
_x000D_
ZIOPHARM Oncology Inc – Key Information _x000D_
ZIOPHARM Oncology Inc – Overview _x000D_
ZIOPHARM Oncology Inc – Key Employees _x000D_
ZIOPHARM Oncology Inc – Key Employee Biographies _x000D_
ZIOPHARM Oncology Inc – Key Operational Heads _x000D_
ZIOPHARM Oncology Inc – Major Products and Services _x000D_
ZIOPHARM Oncology Inc – History _x000D_
ZIOPHARM Oncology Inc – Company Statement _x000D_
ZIOPHARM Oncology Inc – Locations And Subsidiaries _x000D_
ZIOPHARM Oncology Inc – Key Manufacturing facilities _x000D_
Head Office _x000D_
Other Locations & Subsidiaries _x000D_
_x000D_
Section 2 – Company Analysis _x000D_
_x000D_
ZIOPHARM Oncology Inc – Business Description _x000D_
ZIOPHARM Oncology Inc – Corporate Strategy _x000D_
ZIOPHARM Oncology Inc – SWOT Analysis _x000D_
SWOT Analysis – Overview _x000D_
ZIOPHARM Oncology Inc – Strengths _x000D_
ZIOPHARM Oncology Inc – Weaknesses _x000D_
ZIOPHARM Oncology Inc – Opportunities _x000D_
ZIOPHARM Oncology Inc – Threats _x000D_
ZIOPHARM Oncology Inc – Key Competitors _x000D_
_x000D_
Section 3 – Company Financial Performance Charts _x000D_
_x000D_
ZIOPHARM Oncology Inc – Financial Ratios _x000D_
Financial Ratios – Capital Market Ratios _x000D_
Financial Ratios – Annual Ratios _x000D_
Financial Ratios – Interim Ratios _x000D_
Financial Ratios – Ratio Charts _x000D_
_x000D_
Section 4 – Appendix _x000D_
_x000D_
Appendix _x000D_
Methodology _x000D_
Ratio Definitions _x000D_
About GlobalData _x000D_
Contact Us _x000D_
Disclaimer _x000D_
_x000D_
_x000D_
Note*: Some sections may be missing if data is unavailable for the company

List of Tables
_x000D_
ZIOPHARM Oncology Inc, Key Information _x000D_
ZIOPHARM Oncology Inc, Key Ratios _x000D_
ZIOPHARM Oncology Inc, Share Data _x000D_
ZIOPHARM Oncology Inc, Major Products and Services _x000D_
ZIOPHARM Oncology Inc, History _x000D_
ZIOPHARM Oncology Inc, Key Employees _x000D_
ZIOPHARM Oncology Inc, Key Employee Biographies _x000D_
ZIOPHARM Oncology Inc, Key Operational Heads _x000D_
ZIOPHARM Oncology Inc, Other Locations _x000D_
ZIOPHARM Oncology Inc, Subsidiaries _x000D_
ZIOPHARM Oncology Inc, Key Manufacturing facilities _x000D_
ZIOPHARM Oncology Inc, Key Competitors _x000D_
ZIOPHARM Oncology Inc, SWOT Analysis _x000D_
ZIOPHARM Oncology Inc, Ratios based on current share price _x000D_
ZIOPHARM Oncology Inc, Annual Ratios _x000D_
ZIOPHARM Oncology Inc, Interim Ratios _x000D_
Currency Codes _x000D_
Capital Market Ratios _x000D_
Equity Ratios _x000D_
Profitability Ratios _x000D_
Cost Ratios _x000D_
Liquidity Ratios _x000D_
Leverage Ratios _x000D_
Efficiency Ratios

List of Figures
_x000D_
ZIOPHARM Oncology Inc, Performance Chart _x000D_
ZIOPHARM Oncology Inc, Ratio Charts

★海外企業調査レポート[ZIOPHARM Oncology Inc (ZIOP):企業財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EDF Energy Holdings Limited:企業のM&A・提携動向(エネルギー分野)
    Summary EDF Energy Holdings Limited (EDF Energy), a subsidiary of EDF Energy (UK) Limited is an energy utility company. It is one of the major producers of low carbon electricity in the UK. The company carries out the generation, provision and supply of electricity and gas. It generates electricity …
  • Aspen Pharmacare Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aspen Pharmacare Holdings Limit …
  • Flexera Software LLC:企業の戦略的SWOT分析
    Flexera Software LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Oberoi Realty Limited:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Oberoi Realty Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Pt Mandom Indonesia Tbk:企業の戦略・SWOT・財務情報
    Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Gladstone Institutes(製薬・医療分野):企業M&A動向
    Summary Gladstone Institutes (Gladstone) is an independent and nonprofit bio-medical research organization. The institute carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regenerative medicine. It applie …
  • Imaspro Corporation Berhad (IMASPRO):企業の財務及び戦略的SWOT分析
    Summary Imaspro Corporation Berhad (ICB) is a chemical company that manufactures and distributes pesticides and related agrochemicals worldwide. The company’s product segments include herbicide, insecticide, fungicide, and other products. ICB’s fungicide products include benomyl, bordeaux mixture, c …
  • CRH Medical Corp (CRH)-医療機器分野:企業M&A・提携分析
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp is a medical device company that provides treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It provides topical ointments and creams including preparation …
  • Golden Grain Energy, LLC:企業概要及び戦略的SWOT分析
    Golden Grain Energy, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SBI Holdings Inc (8473):企業の財務・戦略的SWOT分析
    SBI Holdings Inc (8473) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Grupo T-Solar Global, S.A.:企業のM&A・提携動向(エネルギー分野)
    Summary GRUPO T-SOLAR GLOBAL, S.A. (T-SOLAR), a subsidiary of Isolux Infrastructure Netherlands B.V. is a solar equipment manufacturer that produces photovoltaic power products. The company offers T-solar modules. It provides services such as designing, construction, installing and operating of sola …
  • Jastec Co., Ltd. (9717):企業の財務及び戦略的SWOT分析
    Summary Jastec Co., Ltd. (Jastec) is an information technology solution provider that offers custom software development and system integration solutions. The company offers products such as business service systems, middle-ware, operating system, process rationalization systems, programming languag …
  • Studsvik AB (SVIK):企業のM&A・提携動向(発電分野)
    Summary Studsvik AB (Studsvik) is a nuclear services company that provides various advanced technical services including consultancy, fuel and materials performance tests, and waste treatment. It offers engineering and consultancy, decommissioning, health physics, operational and outage support, and …
  • Intrexon Corporation (XON)(製薬・医療分野):企業M&A動向
    Summary Intrexon Corporation (Intrexon) is a biotechnology company. The company develops solutions for current and looming challenges. It operates through divisions, such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics …
  • Sorrento Therapeutics Inc (SRNE):企業のM&A・提携動向(医療分野)
    Summary Sorrento Therapeutics Inc (STI), formerly QuikByte Software, Inc., which develops novel treatments for cancer, inflammation and autoimmune diseases. It discovers small molecules, antibody drug conjugates, and antibodies for the treatment of cancer and its associated pain. Its pipeline produc …
  • United States Endoscopy Group, Inc.:企業の戦略的SWOT分析
    United States Endoscopy Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • AGCO Corporation:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on AGCO Corporation providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the core Strengths …
  • The 77 Bank Ltd:企業の戦略・SWOT・財務情報
    The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The 77 Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Apogenix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The company’s pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodyspl …
  • Hindustan Petroleum Corporation Limited:企業の戦略・SWOT・財務情報
    Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Hindustan Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆